Polycystic
Ovary Syndrome (PCOS)
多囊性卵巢症候群
綜論 -key points | |
病理生理及臨床特徵-pathophysiology and clinical features | |
病因-pathogenesis | |
診斷-diagnosis | |
治療-management | |
後遺症-long term sequelae and risks |
綜論 -key points |
*佔生育年齡婦女的4-12%, *是不排卵性不孕症最常見的原因, *有幾個特點:
|
病理生理及臨床特徵-pathophysiology and clinical features |
Clinical features | |||||||||||
|
|||||||||||
Accelerated GnRH/LH pulsatile activity | |||||||||||
|
病因-pathogenesis |
確實的病因雖仍未明朗, 但還是可以歸納出以下幾個可能性: | |||
。Abnormal secretion of pituitary gonadotropins suggests a
hypothalamic origin. 。Abnormal steroidogenesis raises the possibility of adrenal or ovarian origin. 。Insulin resistance points to an abnormality in insulin action. |
|||
Hereditary and Genetic Factors | |||
最近的研究傾向於遺傳或是基因得突變, 其中有些已獲得證實, 這包括如下: | |||
。Study by
Ehrman and colleagues showed
that women with PCOS having a first-degree relative with type 2
diabetes were more likely to have more severe insulin resistance. An
affected woman-unaffected sister pair analysis showed a 55%
correlation of dehydroepiandrosterone sulfate (DHEAS) levels
suggesting an inherited problem with adrenal androgen production. 。很多PCOS的病人, 其 PvuII polymorphism of the estrogen receptor gene的機率增高 , 這可以解釋為什麼PCOS的病人會有不正常的 ovarian estrogen action. 。一些研究則發現PCOS的病人, 其Gly972Arg polymorphism of insulin receptor substrate (IRS)-1/增加很多, 這又可以解釋為什麼PCOS的病人會insulin resistance. 。Escobar-Morreale 則發現到PCOS的病人,其tumor necrosis factor (TNF)-receptor polymorphism很顯著的升高, 所以TNF system的受到侵犯, 應也與PCOS的病因有關. |
診斷-diagnosis |
診斷的原則 | |||
The most widely accepted diagnostic criteria are the National Institute of Child Health and Human Development (NICHD) criteria: clinical or laboratory evidence of hyperandrogenism without other endocrine disorder and oligoanovulation. | |||
依據臨床徵象Clinical Presentation | |||
肥胖(obesity), 多毛(hirsutism),月經不規則(ovarian acyclicity), 或無月經. | |||
依據檢驗數據Laboratory Diagnosis | |||
。ultrasonography
shows enlarged ovaries with increased stroma and multiple subcapsular
small follicles. 。reveals elevated serum androgen levels (total and free testosterone, androstenedione), 。increased luteinizing hormone (LH)/follicle-stimulating hormone ratio, 。decreased sex-hormone binding globulin (SHBG) levels, 。lipid abnormalities, and insulin resistance. |
治療-management |
Anovulation | ||
Dysfunctional Uterine Bleeding | ||
Metabolic Abnormalities | ||
PCOS的長期後遺症-long term sequelae and risks |
Endometrial Cancer子宮內膜癌 | ||
Diabetes Mellitus糖尿病 | ||
Cardiovascular Disease心血管疾病 | ||